Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 1998

View Archived Issues

Targeted cytotoxic LHRH analogues show potential as Rx for breast cancer

Dynavax and Vical crosslicense DNA immunization technology

Company Profile: Penwest

Glaxo Wellcome's R&D pipeline remains full and diverse

Genzyme Molecular Oncology, Schering-Plough collaborate to make gene therapy a reality

Novel antifungal peptides isolated by Hoechst Marion Roussel

Vertex describes new MDR-modulating and neuritogenic agents

HIV protease inhibitor research continues at DuPont Merck

Boehringer Ingelheim develops new antiplatelet agents

BMS claims new beta3-adrenoceptor agonists

Antiviral agents that inhibit virus-host cell fusion pursued by Lilly

Duphar presents new vitamin D analogues

Antiprogestational agents with reduced antiglucocorticoid activity claimed by HHS

Hemodynamic profile of new K+ channel activator

Selective inhibitor of PDGF receptor autophosphorylation from Kirin Brewery

New chelating agent developed by Israeli researchers

Pharmacological profile of broad-spectrum, nonopioid analgesic described by Abbott

Novel antitumor cyanoguanidines with good oral bioavailability

Novel coronary artery disease gene therapy scheduled to enter clinical trials

PDMP analogues studied for malaria inhibition

Potential target for a malaria vaccine identified

Johns Hopkins researchers synthesize antimalarial drug candidates

European filing announced for Savedar (DepoCyt)

Malaria vaccine research under way at Gryphon Sciences

Antischistosomal agent derived from myrrh tested in humans

AHP and SKB to merge?

Combination HCV therapy receives priority classification from FDA

Pfizer to develop Nastech formulation of sleep aid

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...